Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

UDI Deadlines Extended for Some Devices

The FDA wants to avoid potential manufacturing disruptions.

In an effort to avoid disrupting access to medical devices, the FDA is extending deadlines for some unique device identifier requirements, according to Regulatory Focus.

According to the article, the FDA will not "enforce a statutory prohibition on National Health Related Item Code or National Drug Code numbers for device labels and packaging for certain devices manufactured prior to 24 September 2018 until 24 September 2021."

This specifically includes finished class III devices, devices listed under the Public Health Service Act, class II devices and implantable, life-supporting, or life-sustaining devices.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging